Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
NCT01956734
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Recurrent Tumor
Interventions
PROCEDURE:
DNX2401 and Temozolomide
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators
[object Object]